Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Mylinax – Novel Therapy for the Treatment of

Drug (Brand / Generic)

Mylinax (a proprietary oral formulation of cladribine)

Company / Licensee

IVAX Corporation, Serono

Therapy Class

Immunomodulatory agent

Product Description

Lymphocytotoxic agent

Current Indication

Treatment of multiple sclerosis

Market Sector

CNS

Development Status

Phase III
Expand

Go Top